Asthma Severe Flashcards

1
Q

What percentage of pediatric asthma is likely accounted for by refractory asthma?

A

Less than 5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define severe asthma.

A

Patient requires treatment with guideline-suggested medications for GINA steps 4–5 asthma for the previous year OR systemic corticosteroids for ≥50% of the previous year OR remains ‘uncontrolled’ despite this therapy OR controlled asthma that worsens on tapering of high doses of ICS or systemic CS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is defined as uncontrolled asthma?

A

One or more of the following: poor symptom control, frequent severe exacerbations, serious exacerbations, airflow limitation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does poor symptom control consist of?

A

ACQ consistently >1.5, ACT <20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is frequent severe exacerbation defined?

A

Two or more bursts of systemic corticosteroids (>3 days each) in the previous year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What constitutes a serious exacerbation?

A

At least one hospitalization, ICU stay, or mechanical ventilation in the previous year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What airflow limitation indicates uncontrolled asthma?

A

FEV1 <80% predicted after withholding bronchodilators.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is fixed airflow limitation?

A

FEV1 <80% predicted despite a trial of systemic steroids and acute administration of SABA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the three types of severe asthma defined by WHO?

A
  • Untreated
  • Difficult-to-treat
  • Treatment-resistant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List the domains of asthma severity used to define risk.

A
  • Level of prescribed treatment
  • Level of baseline asthma control
  • Level of underlying airway eosinophilia
  • Burden and nature of exacerbations
  • Risk of future complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What should the initial assessment of problematic severe asthma focus on?

A

Extra-pulmonary disease and environmental/lifestyle factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the significance of normal spirometry in children with severe asthma?

A

Normal spirometry does not exclude severe asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does a methacholine challenge test assess?

A

Airway hyperresponsiveness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is fractional exhaled nitric oxide (FeNO) used for?

A

Diagnostic tool for asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

True or False: A low FeNO50 excludes asthma.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are red flags in the differential diagnosis of problematic severe asthma?

A
  • Neonatal onset of symptoms
  • Chronic productive cough for more than 8 weeks
  • Evidence of systemic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How can obesity affect asthma?

A

It may cause breathlessness and wheeze without evidence of asthma, and can be associated with steroid resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the relationship between gastroesophageal reflux and asthma?

A

Reflux can cause symptoms that mimic or coexist with asthma.

19
Q

How should food allergy be documented?

A

With a double-blind challenge unless there is overwhelming evidence for the diagnosis.

20
Q

What is the role of psychosocial morbidity in asthma?

A

Acute and chronic stress may trigger asthma exacerbations.

21
Q

What is the purpose of a hospital admission for assessment in asthma?

A

To evaluate symptoms and manage treatment under supervision.

22
Q

What are the components of airway disease in severe asthma?

A
  • Airway inflammation
  • Airway infection
  • Airway obstruction
  • Mucus production
  • Eosinophilia
  • Neutrophilia
23
Q

What is the protocol for invasive investigation of severe, therapy-resistant asthma?

A

Assess symptoms, spirometry, and perform bronchoscopy with BAL and biopsy.

24
Q

What cytokines are implicated in pediatric severe, therapy-resistant asthma?

A
  • GRO (CXCL1)
  • RANTES (CCL5)
  • IL-12
  • IFN-γ
  • IL-10
25
What is a characteristic of induced sputum in severe asthma?
Eosinophil dominated.
26
Fill in the blank: A cough in severe asthma is a _______ phenomenon.
secondary
27
What cytokines best discriminate between severe, therapy-resistant asthma and mild-moderate disease?
GRO (CXCL1), RANTES (CCL5), IL-12, IFN-γ, IL-10 ## Footnote These cytokines play a significant role in distinguishing between different asthma severities.
28
Is pediatric severe, therapy-resistant asthma a TH1- or TH2-driven disease?
Neither ## Footnote This indicates a different underlying mechanism compared to typical TH1 or TH2 asthma.
29
Which epithelial-derived cytokines may be implicated in pediatric severe asthma?
IL-25, IL-33, TSLP ## Footnote These cytokines are thought to play a role in the pathogenesis of severe asthma.
30
What is the role of IL-33 in pediatric severe asthma?
Steroid resistant and promotes collagen synthesis from fibroblasts ## Footnote Increased IL-33 expression is associated with structural changes in the airways.
31
What is the definition of persistent airflow limitation (PAL)?
FEV1 <80% despite a trial of systemic steroids and acute administration of SABA ## Footnote This definition is used to assess long-term asthma control.
32
What percentage of children with severe asthma are total nonresponders to steroids?
About 10% ## Footnote This reflects the variability in response to steroid treatments among children.
33
What is the recommended duration for a trial of omalizumab?
16 weeks ## Footnote Detailed monitoring of the response is necessary during this period.
34
What is the pragmatic decision for diagnosing PAL?
Provisionally diagnosed after a single dose of triamcinolone and albuterol ## Footnote This approach helps in managing difficult cases of asthma.
35
What is the starting dose for oral prednisolone in children?
0.5 mg/kg, tapering down to the lowest dose needed ## Footnote This is a non-evidence-based starting dose used in practice.
36
What is the SMART regime used for?
To simplify treatment for adolescents with asthma ## Footnote This approach aims to manage symptoms effectively with fewer medications.
37
What are the possible approaches for using nonstandard medications in severe asthma?
Macrolide antibiotics, immunosuppressives, intravenous Ig, continuous subcutaneous infusion of terbutaline ## Footnote These options may be considered for specific phenotypes or conditions.
38
What is the risk associated with antifungal treatment in asthma?
Interaction with ICS leading to iatrogenic Cushing syndrome ## Footnote This potential side effect must be monitored carefully.
39
What is the definition of SAFS?
Defined in Table 46.4 ## Footnote SAFS stands for Severe Asthma with Fungal Sensitization, a specific asthma phenotype.
40
What factors predict asthma lung attacks in older children?
Respiratory viral infection, sensitization, exposure to high allergen levels ## Footnote These factors are critical in understanding and preventing acute asthma attacks.
41
What is the recommended treatment for children with multiple asthma lung attacks?
Increase the baseline dose of ICS ## Footnote This aims to control eosinophilic inflammation and improve overall management.
42
What is the recommended annual assessment for children with severe asthma?
Reevaluation of adherence, allergen exposure, spirometry, and side effects monitoring ## Footnote This assessment helps in adjusting treatment plans effectively.
43
What is the role of the Synacthen test in monitoring children with severe asthma?
To assess adrenal insufficiency ## Footnote This test is recommended annually to monitor potential side effects of steroid treatments.